Eastwood Bio-Medical Canada Inc. (TSXV:EBM)

Market Cap	28.93M
Revenue (ttm)	657.38K
Net Income (ttm)	-469.61K
Shares Out	68.89M
EPS (ttm)	-0.01
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	9,700
Average Volume	3,738
Open	0.4100
Previous Close	0.4200
Day's Range	0.4100 - 0.4250
52-Week Range	0.2800 - 1.1500
Beta	-0.36
RSI	51.65
Earnings Date	Sep 26, 2025

About ATSG

Eastwood Bio-Medical Canada Inc. markets and distributes natural health products under the Eleotin brand in Canada, the United States, and Asia. The company distributes Eleotin, which provides natural remedies for metabolic disorders, such as blood glucose disorders, hypertension, and obesity. Its licensed products include Eleotin A 700 for the treatment for spleen deficiency, lack of appetite, and fatigue; Eleotin AL88 for laxative; Eleotin Cal20 for bone and teeth maintenance; Eleotin V3D for development and maintenance of bones, teeth, and g...

• Industry: Food Distribution
• Sector: Consumer Staples
• Founded: 2010
• Country: Canada
• Stock Exchange: TSX Venture Exchange
• Ticker Symbol: EBM

Financial Performance

In 2024, TSXV:EBM's revenue was 702,076, a decrease of -19.11% compared to the previous year's 867,936. Losses were -455,870, -16.60% less than in 2023.